Streetbeat News

Regulatory

IRON

Disc Medicine, Inc. (NASDAQ:IRON) will host a conference call on November 4 to discuss feedback from its end-of-Phase 2 FDA meeting for Bitopertin, a treatment for erythropoietic protoporphyria.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 8:03 pm

GLASF

HITI

TLRY

The article discusses how top cannabis companies, Tilray, High Tide, and Glass House Brands, are navigating financial pressures and regulatory uncertainties. High Tide shows positive growth with market expansion and a strong loyalty program. Tilray faces operational losses despite revenue growth, focusing on potential acquisitions to strengthen its medical cannabis segment. Glass House Brands aims for cost leadership in cultivation, with plans to reduce production costs and expand operations. The cannabis sector remains resilient amid market pressures and election uncertainties.

Portfolio Pulse from Patricio Liddle

November 01, 2024 | 8:03 pm

UPC

Universe Pharmaceuticals INC (NASDAQ:UPC) has received a notification from Nasdaq regarding non-compliance with the minimum bid price requirement, as its share price has fallen below $1.00 for 30 consecutive business days.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 8:02 pm

META

Meta Platforms Inc. has lost its appeal in the UK regarding a class action lawsuit that accuses Facebook of abusing its dominant position and exploiting user data. The UK's Court of Appeal upheld a previous decision allowing the lawsuit to proceed.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 7:32 pm

CBOE

COIN

21Shares has filed for a spot XRP ETF with the SEC, aiming to list it on the Cboe BZX Exchange. This move is part of a broader trend of investment firms seeking to expand access to cryptocurrency through ETFs, despite ongoing legal challenges involving Ripple and the SEC.

Portfolio Pulse from Khyathi Dalal

November 01, 2024 | 7:16 pm

VNDA

HC Wainwright initiated coverage on Vanda Pharmaceuticals (NASDAQ:VNDA) with a Buy rating and a price target of $18, citing its undervaluation and robust portfolio. Despite challenges like generic competition and a recent FDA CRL, Vanda's strong sales and pipeline make it an attractive M&A target.

Portfolio Pulse from Vandana Singh

November 01, 2024 | 6:05 pm

X

US Steel reported Q3 earnings with a profit of 56 cents per share, surpassing expectations. Revenue was $3.85 billion, also exceeding forecasts. The company raised its 2024 capex to $2.3 billion due to cost overruns, with plans to reduce it in 2025. Analysts have mixed views, with some concerns about pricing and regulatory issues.

Portfolio Pulse from Henry Khederian

November 01, 2024 | 6:04 pm

BTCUSD

Economist Alex Krüger predicts Bitcoin's price could reach $79,000 by year-end, influenced by the 2024 U.S. presidential election outcome. A Trump win could push Bitcoin to $90,000, while a Harris victory might keep it around $65,000. Krüger emphasizes Bitcoin's correlation with equity markets and the potential impact of a Democratic sweep.

Portfolio Pulse from Murtuza Merchant

November 01, 2024 | 4:50 pm

NXL

Nexalin Technology's shares rose after the company announced it regained compliance with Nasdaq's listing requirements.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 4:07 pm

SPY

The October jobs report showed a significant slowdown in job growth, with only 12,000 jobs added, far below expectations. Economists attribute this to hurricanes and strikes, and anticipate the Federal Reserve will cut interest rates by 0.25% at its next meeting. The SPDR S&P 500 ETF Trust (SPY) rose 1.14% on rate cut expectations.

Portfolio Pulse from Erica Kollmann

November 01, 2024 | 4:01 pm